Blonder Tongue Laboratories (BDR) saw its loss narrow to $0.64 million, or $0.08 a share for the quarter ended Sep. 30, 2016. In the previous year period, the company reported a loss of $1.96 million, or $0.30 a share.     

Revenue during the quarter dropped 4.77 percent to $5.43 million from $5.70 million in the previous year period. Gross margin for the quarter expanded 2144 basis points over the previous year period to 35 percent. Operating margin for the quarter stood at negative 7.62 percent as compared to a negative 32.87 percent for the previous year period.

Operating loss for the quarter was $0.41 million, compared with an operating loss of $1.88 million in the previous year period.

Commenting on the third quarter, chief executive officer Robert J. Palle noted, "Our results for the third quarter 2016 fell short of expectations. Although net sales were only slightly less than expected, several factors adversely impacted gross margin when compared to the second quarter of 2016; specifically, increased internal facilities expenses, a reduction in overhead-in-inventory value as a result of overhead expense reduction, and a less favorable product mix. We believe that net sales will remain flat through the remainder of 2016 and into the first quarter of 2017. On a positive note, we received several significant orders for newly introduced products during the quarter, and sales of those products should increase as 2017 unfolds. In the near term, we remain focused on achieving positive EBITDA, refinancing the revolver and term loan with a new lender, and completing the development of the new products that are also expected to contribute to increased sales in 2017."

Days sales outstanding went down to 19 days for the quarter compared with 36 days for the same period last year.